Morgan Rosel Wealth Management, LLC Novartis Ag Transaction History
Morgan Rosel Wealth Management, LLC
- $313 Million
- Q1 2025
A detailed history of Morgan Rosel Wealth Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Morgan Rosel Wealth Management, LLC holds 675 shares of NVS stock, worth $75,694. This represents 0.02% of its overall portfolio holdings.
Number of Shares
675Holding current value
$75,694% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,497Shares Held
130MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.37 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.24 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$918 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$770 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$625 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $241B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...